Center Care (Meritain) policies

Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

69 policies name 96401, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Center Care (Meritain) policies
PolicyDetailsCodesSource
0977-Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo)0977 · Commercial2Original policy ↗
0947-Tagraxofusp-erzs (Elzonris)0947 · Commercial3Original policy ↗
1062-Tarlatamab-dlle (Imdelltra)1062 · Commercial3Original policy ↗
0960-Azacitidine0960 · Commercial4Original policy ↗
1085-Telisotuzumab Vedotin-tllv (Emrelis)1085 · Commercial4Original policy ↗
Romidepsin0865 · Commercial4Original policy ↗
0959-Pegaspargase (Oncaspar)0959 · Commercial5Original policy ↗
1025-Mosunetuzumab-axgb (Lunsumio and Lunsumio Velo)1025 · Commercial5Original policy ↗
Scalp Cooling (Hypothermia) to Prevent Hair Loss During Chemotherapy0290 · Commercial5Original policy ↗
0361-Strontium Chloride Sr-890361 · Commercial6Original policy ↗
0683-Oxaliplatin0683 · Commercial6Original policy ↗
0895-Dinutuximab (Unituxin)0895 · Commercial7Original policy ↗
1064-Crovalimab-akkz (PiaSky)1064 · Commercial7Original policy ↗
0864-Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn (Rylaze)0864 · Commercial8Original policy ↗
1034-Epcoritamab-bysp (Epkinly)1034 · Commercial8Original policy ↗
Hematopoietic Cell Transplantation for Testicular Cancer0617 · Commercial8Original policy ↗
0659-Ibritumomab Tiuxetan (Zevalin)0659 · Commercial9Original policy ↗
0974-Ado-trastuzumab emtansine (Kadcyla)0974 · Commercial9Original policy ↗
Hematopoietic Cell Transplantation for Ovarian Cancer0635 · Commercial9Original policy ↗
0802-Sipuleucel-T (Provenge)0802 · Commercial10Original policy ↗
0900-Talimogene Laherparepvec (Imlygic)0900 · Commercial10Original policy ↗
0942-Cemiplimab (Libtayo)0942 · Commercial10Original policy ↗
0949-Caplacizumab-yhdp (Cablivi)0949 · Commercial10Original policy ↗
1040-Elranatamab-bcmm (Elrexfio)1040 · Commercial10Original policy ↗
Motixafortide (Aphexda)1046 · Commercial13Original policy ↗
Hereditary Angioedema0782 · Commercial14Original policy ↗
0842-Ziv-Aflibercept (Zaltrap)0842 · Commercial15Original policy ↗
1042-Talquetamab-tgvs (Talvey)1042 · Commercial15Original policy ↗
1048-Mirikizumab-mrkz (Omvoh)1048 · Commercial15Original policy ↗
Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma0494 · Commercial16Original policy ↗
0966-Fam-trastuzumab Deruxtecan-nxki (Enhertu)0966 · Commercial17Original policy ↗
1018-Teclistamab-cqyv (Tecvayli)1018 · Commercial17Original policy ↗
Hematopoietic Cell Transplantation for Selected Leukemias0640 · Commercial17Original policy ↗
0684-Cetuximab (Erbitux)0684 · Commercial18Original policy ↗
0902-Irinotecan Liposome Injection (Onivyde)0902 · Commercial21Original policy ↗
Hematopoietic Cell Transplantation for Multiple Myeloma0497 · Commercial21Original policy ↗
0919-Inotuzumab Ozogamicin (Besponsa)0919 · Commercial22Original policy ↗
0675-Bortezomib Products0675 · Commercial23Original policy ↗
Hematopoietic Cell Transplantation for Hodgkin's Disease0495 · Commercial23Original policy ↗
Hematopoietic Cell Transplantation for Selected Childhood Solid Tumors0496 · Commercial25Original policy ↗
0804-Denosumab0804 · Commercial27Original policy ↗
Hematopoietic Cell Transplantation for Thalassemia Major and Sickle Cell Anemia0626 · Commercial27Original policy ↗
1035-Rozanolixizumab-noli (Rystiggo)1035 · Commercial28Original policy ↗
Trastuzumab Products0313 · Commercial28Original policy ↗
Gonadotropin-Releasing Hormone Analogs and Antagonists0501 · Commercial29Original policy ↗
0195-Erythropoesis Stimulating Agents0195 · Commercial32Original policy ↗
Voice Therapy0646 · Commercial32Original policy ↗
0685-Bevacizumab for Non-Ocular Indications0685 · Commercial33Original policy ↗
0897-Mepolizumab (Nucala)0897 · Commercial38Original policy ↗
0024-Aldesleukin (Proleukin)0024 · Commercial39Original policy ↗

Back to Center Care (Meritain)

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.